Source:http://linkedlifedata.com/resource/pubmed/id/17056500
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
2006-10-23
|
pubmed:abstractText |
CD1d-restricted NKT cells play important regulatory roles in various immune responses and are rapidly and selectively depleted upon infection with HIV-1. The cause of this selective depletion is incompletely understood, although it is in part due to the high susceptibility of CD4+ NKT cells to direct infection and subsequent cell death by HIV-1. Here, we demonstrate that highly active antiretroviral therapy (HAART) results in the rapid recovery of predominantly CD4(-) NKT cells with kinetics that are strikingly similar to those of mainstream T cells. As it is well known that the early recovery of mainstream T cells in response to HAART is due to their redistribution from tissues to the circulation, our data suggest that the selective depletion of circulating NKT cells is likely due to a combination of cell death and tissue sequestration and indicates that HAART can improve immune functions by reconstituting both conventional T cells and immunoregulatory NKT cells.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0022-1767
|
pubmed:author |
pubmed-author:BontkesHetty JHJ,
pubmed-author:DannerSven ASA,
pubmed-author:MollingJohan WJW,
pubmed-author:ReijmMartineM,
pubmed-author:ReissPeterP,
pubmed-author:ScheperRik JRJ,
pubmed-author:van AgtmaelMichiel AMA,
pubmed-author:van VonderenMarit G AMG,
pubmed-author:van den EertweghAlfons J MAJ,
pubmed-author:van der VlietHans J JHJ,
pubmed-author:von BlombergB Mary EBM
|
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
177
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
5775-8
|
pubmed:meshHeading |
pubmed-meshheading:17056500-Adult,
pubmed-meshheading:17056500-Aged,
pubmed-meshheading:17056500-Antigens, CD4,
pubmed-meshheading:17056500-Antiretroviral Therapy, Highly Active,
pubmed-meshheading:17056500-HIV Infections,
pubmed-meshheading:17056500-HIV-1,
pubmed-meshheading:17056500-Humans,
pubmed-meshheading:17056500-Killer Cells, Natural,
pubmed-meshheading:17056500-Middle Aged,
pubmed-meshheading:17056500-T-Lymphocyte Subsets
|
pubmed:year |
2006
|
pubmed:articleTitle |
Cutting edge: Rapid recovery of NKT cells upon institution of highly active antiretroviral therapy for HIV-1 infection.
|
pubmed:affiliation |
Department of Internal Medicine, Vrije Universiteit Medical Centre, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands. jj.vandervliet@vumc.nl
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|